Growing your Medical Technology Business through Financing, M&A and Strategic Partnerships

Invest, Partner and Network with the Most Promising Early- to Late-Stage Medical Technology Companies and the Biggest Deal Makers in the Medtech Business Development and Investment Communities

For more information on In3 West 2009, taking place March 2-4 at The Palazzo in Las Vegas, please contact Kristy Grimes at 480-985-9512, 888-202-5939 toll-free in the U.S., or e-mail in3@windhover.com

Investment-in-Innovation (In3) conferences are the premier forums worldwide for discerning senior executives in the medical device, diagnostics, biotech, and pharmaceutical business development and investment communities to meet and screen promising medical technology companies in need of funding, acquisition and/or strategic partnership, and to network with key decision makers in the industry. Click here to see a video describing why you should attend IN3 conferences: Launch Video

Program Benefits: Hear presentations from 50+ promising early- to late-stage device companies, each followed by one-on-one meetings in private breakout rooms Network with 350+ key deal makers in the device and investment communities Gain valuable, actionable insight with plenary sessions by device industry thought leaders sharing their in-the-trenches experiences in building, funding and selling their companies Get a head start on 2009 with a number of informative and interactive panel discussions, focusing on hot-button topics impacting the worldwide device and investment communities Presenting company product exhibition/reception … and much, much more! – to be announced soon! Presentations from our hand-selected group of cutting-edge, early- to late-stage companies will encompass a wide variety of high-growth device sectors, including: Cardiovascular Therapeutics and Diagnostics/Interventional Cardiology Device Coatings/Biocompatible Technology Diagnostics Drug Delivery Electrosurgery Imaging Minimally Invasive Surgery Nanotechnology Neurostimulation Oncology Diagnostics and Therapeutics Ophthalmic Technology Orthopedics/Spine Peripheral Vascular Stem Cells Stroke Management Surgical Adhesives/Sealants Tissue Engineering Wound Management ... to mention only a few.

Advisory Board Jeffrey Barnes General Partner Oxford Bioscience Partners Michael Carusi General Partner Advanced Technology Ventures Luke Evnin General Partner MPM Capital Richard M. Ferrari Managing Director DeNovo Ventures William T. Harrington Partner Three Arch Partners Ross A. Jaffe Managing Director Versant Ventures Ellen Koskinas Partner InterWest Partners Josh Makower Venture Partner NEA John Maroney General Partner Delphi Ventures Allan May Chairman, Founder Life Science Angels Managing Director Emergent Medical Partner David Milne Managing Partner SV Life Science Advisers Trevor J. Moody Partner Frazier Healthcare Ventures Jesse I Treu Partner Domain Associates

Presenting Companies

Benefits of Attending:

• Potential acquirers/funding partners will able to meet and screen over 50 first-rate investment possibilities in just 2 well-orchestrated days, via focused presentations covering their widely varied technologies, stage of development and testing, potential markets, management teams, regulatory timeline, patent protection, competitive strategy, funding needed, among many other key details, and private break-out sessions, among many other networking opportunities.
  
• Medical device start-ups face intense competition for a finite amount of available capital funding: In3 West Las Vegas ‘09 is an ideal setting for emerging company management teams to meet and impress potential investors, from many of the heavy-hitting, top-tier device companies and discerning healthcare investment firms from around the world.
  
• All attendees will gain a keen understanding in a short timeframe of the emerging medical technologies on course to make a distinct impact on the intensely competitive and evidence-driven device industry in the next few years. Register to attend today and get ready to tap into the many opportunities about to emerge in the medtech space!

Proudly, In3 West Las Vegas 2009 is Medtech Insight/Windhover Information/Elsevier’s 33rd In3 event. These first-rate events have established a reputation as the most important venue of their kind for key investors interested in the medical device space.

Our February 2008 event at The Venetian was a huge success, with rave reviews from presenters and attendees – Las Vegas 2009 is definitely a do-not-miss opportunity for those interested in investing, partnering and networking with the best-of-the-best emerging medtech companies, along with key decision-makers in the device and investment communities.

We have a long and strong track record: Over 1500 emerging medical technology company presenters and more than 8000 attendees have participated at In3 events over the past 8 years. We are very proud that many young companies have worked their way up the funding ladder and into the marketplace via the relationships they formed at In3 events. Click here for success stories and testimonials from our past presenters and attendees.

Attendees will include:

• Presidents
• CEOs, CTOs, COOs
• Founders, Chairpersons
• Venture Partners
• Managing Directors
• Vice Presidents/Directors of Strategic Planning, Business Development, Marketing, New Technology, Acquisitions, R&D and Sales
• Senior Investment Analysts/Principals/Directors

…. from these types of companies:

• Established medical technology companies seeking technology through licensing, partnering and acquisition to broaden or deepen product lines or build sector strength
• Venture capitalists and investment bankers, and
• Medical device, biotech, biopharmaceutical or other company executives seeking investments or partnerships

We are expecting a record number of participants at In3 West 2009, from both the buy and sell side – hurry and secure your spot today!

Program Agenda

*Cancellation Policy: The last day to cancel your registration for a refund, minus a $300 processing fee, is January 25, 2009. After that, you may send another delegate from your company.